Zyvorx
About
What does Zyvorx do?
Zyvorx is a biotechnology company that leverages artificial intelligence and computational biology to accelerate the discovery and development of novel therapeutics. Their platform aims to streamline the drug development process, from target identification to lead optimization, by integrating advanced computational methods.
When was Zyvorx founded?
Zyvorx was founded in 2026.
What industry does Zyvorx operate in?
Zyvorx operates in Biotech, Drug Discovery, AI Drug Discovery, Computational Biology, HealthTech, MedTech.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 2 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.